Senseonics (SENS) Competitors $0.44 -0.01 (-2.48%) As of 11:36 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SENS vs. EYPT, ALNT, AEHR, TRNS, CTKB, LAB, FEIM, QSI, QTRX, and MASSShould you be buying Senseonics stock or one of its competitors? The main competitors of Senseonics include Eyepoint Pharmaceuticals (EYPT), Allient (ALNT), Aehr Test Systems (AEHR), Transcat (TRNS), Cytek Biosciences (CTKB), Standard BioTools (LAB), Frequency Electronics (FEIM), Quantum-Si (QSI), Quanterix (QTRX), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry. Senseonics vs. Its Competitors Eyepoint Pharmaceuticals Allient Aehr Test Systems Transcat Cytek Biosciences Standard BioTools Frequency Electronics Quantum-Si Quanterix 908 Devices Eyepoint Pharmaceuticals (NASDAQ:EYPT) and Senseonics (NYSE:SENS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations, earnings and media sentiment. Does the media favor EYPT or SENS? In the previous week, Eyepoint Pharmaceuticals had 5 more articles in the media than Senseonics. MarketBeat recorded 5 mentions for Eyepoint Pharmaceuticals and 0 mentions for Senseonics. Eyepoint Pharmaceuticals' average media sentiment score of 0.96 beat Senseonics' score of 0.00 indicating that Eyepoint Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Eyepoint Pharmaceuticals Positive Senseonics Neutral Which has more volatility & risk, EYPT or SENS? Eyepoint Pharmaceuticals has a beta of 1.93, meaning that its stock price is 93% more volatile than the S&P 500. Comparatively, Senseonics has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500. Which has better valuation & earnings, EYPT or SENS? Senseonics has lower revenue, but higher earnings than Eyepoint Pharmaceuticals. Eyepoint Pharmaceuticals is trading at a lower price-to-earnings ratio than Senseonics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEyepoint Pharmaceuticals$43.27M21.39-$130.87M-$2.68-5.01Senseonics$25.47M14.20-$60.39M-$0.10-4.44 Do analysts rate EYPT or SENS? Eyepoint Pharmaceuticals presently has a consensus price target of $26.86, suggesting a potential upside of 99.98%. Senseonics has a consensus price target of $1.54, suggesting a potential upside of 246.28%. Given Senseonics' stronger consensus rating and higher possible upside, analysts clearly believe Senseonics is more favorable than Eyepoint Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Eyepoint Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Senseonics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.40 Is EYPT or SENS more profitable? Eyepoint Pharmaceuticals has a net margin of -337.93% compared to Senseonics' net margin of -362.30%. Eyepoint Pharmaceuticals' return on equity of -63.80% beat Senseonics' return on equity.Company Net Margins Return on Equity Return on Assets Eyepoint Pharmaceuticals-337.93% -63.80% -50.72% Senseonics -362.30%-842.25%-67.99% Do insiders and institutionals have more ownership in EYPT or SENS? 99.4% of Eyepoint Pharmaceuticals shares are held by institutional investors. Comparatively, 12.4% of Senseonics shares are held by institutional investors. 4.5% of Eyepoint Pharmaceuticals shares are held by insiders. Comparatively, 3.6% of Senseonics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryEyepoint Pharmaceuticals beats Senseonics on 11 of the 17 factors compared between the two stocks. Get Senseonics News Delivered to You Automatically Sign up to receive the latest news and ratings for SENS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SENS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SENS vs. The Competition Export to ExcelMetricSenseonicsProcess control instruments IndustryMedical SectorNYSE ExchangeMarket Cap$363.35M$182.53M$5.78B$21.49BDividend YieldN/AN/A5.74%3.50%P/E Ratio-3.43N/A77.0830.02Price / Sales14.207.15507.1076.45Price / CashN/AN/A37.1724.62Price / Book6.346.3913.694.59Net Income-$60.39M-$31.84M$3.29B$999.97M7 Day Performance-3.48%-2.83%3.23%1.71%1 Month Performance-2.72%-2.06%8.37%6.06%1 Year Performance20.95%21.77%82.31%15.44% Senseonics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SENSSenseonics1.9992 of 5 stars$0.44-2.5%$1.54+246.3%+11.0%$363.35M$25.47M-3.4390EYPTEyepoint Pharmaceuticals1.803 of 5 stars$13.65-2.6%$26.86+96.8%+54.4%$940.89M$43.27M-5.09120Positive NewsALNTAllient2.6848 of 5 stars$45.76+0.5%$35.00-23.5%+133.1%$771.77M$519.60M53.212,525Positive NewsAEHRAehr Test Systems1.9694 of 5 stars$25.19-1.4%N/A+152.6%$753.69M$58.97M-193.7590TRNSTranscat3.8716 of 5 stars$79.71+2.0%$112.20+40.8%-41.0%$742.90M$278.42M55.741,245Positive NewsShort Interest ↑CTKBCytek Biosciences2.028 of 5 stars$4.10+2.0%$5.60+36.6%-19.2%$521.62M$196.04M-82.00500Positive NewsLABStandard BioTools2.5597 of 5 stars$1.36+4.6%$1.55+14.0%-30.5%$519.51M$172.27M-4.25620Positive NewsFEIMFrequency Electronics3.1205 of 5 stars$32.64+3.3%N/A+157.3%$318.24M$69.81M13.21200Analyst ForecastQSIQuantum-Si1.938 of 5 stars$1.06-1.9%$3.48+227.8%+53.0%$214.65M$3.41M-1.56150Gap DownQTRXQuanterix1.8791 of 5 stars$4.52-0.7%$11.75+160.0%-60.5%$210.04M$137.42M-2.48460Positive NewsMASS908 Devices2.6845 of 5 stars$5.64+3.7%$8.00+41.8%+84.8%$202.25M$59.63M-10.4460 Related Companies and Tools Related Companies EYPT Alternatives ALNT Alternatives AEHR Alternatives TRNS Alternatives CTKB Alternatives LAB Alternatives FEIM Alternatives QSI Alternatives QTRX Alternatives MASS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SENS) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senseonics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Senseonics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
